Practice-Changing Medicine

‘Freezing Away’ Advanced Lung Cancer

First-in-human phase 1 trial evaluating bronchoscopic cryoimmunotherapy in advanced NSCLC shows promising results.

Advancing Science

Oral Microbiome Signatures Associated with Elevated Pancreatic Cancer Risk

JAMA Oncology study links 27 species of oral microbes to a nearly 3.5 times greater risk of developing pancreatic cancer.

Expert Perspectives

Efficacy Without Excess Is Reshaping Breast Cancer Trials

Clinical trialist Dr. Douglas Marks discusses NYU Langone’s extensive breast cancer trial portfolio and approaches to lowering treatment toxicity. 

Expert Perspectives

Putting Translational Oncology to Work

Dr. Manuel Hidalgo, renowned translational researcher and co-director of the new GI Cancer Center, reflects on his career advancing anticancer agents and his vision for the center.
Dr. Maitra’s headshot

Expert Perspectives

Advancing Early Detection of GI Cancer

Dr. Anirban Maitra, acclaimed cancer leader and co-director of the new GI Cancer Center, discusses a team-based approach to intercepting GI cancer and delivering innovative care.

Expert Perspectives

New Medical Director Is Building the Future of Cancer Immunotherapy at NYU Langone

Samuel Yamshon, MD, shares how he’s scaling research and infrastructure for cutting-edge cellular therapies across—and beyond—cancer care.
Load More